Ticker Details
RenovoRx, Inc.
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$59.57M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 5.15%
Avg Daily Range (30 D):	$0.04 | 4.06%
Avg Daily Range (90 D):	$0.03 | 3.34%

Institutional Daily Volume
Avg Daily Volume:	.35M
Avg Daily Volume (30 D):	.31M
Avg Daily Volume (90 D):	.27M

Trade Size
Avg Trade Size (Sh.):	222
Avg Trade Size (Sh.) (30 D):	306
Avg Trade Size (Sh.) (90 D):	367

Institutional Trades
Total Institutional Trades:	8
Avg Institutional Trade:	$1.13M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Apr 1, 2026 @ 6:20 PM RenovoRx Named to Fast Company’s Annual Lis... Source: Renovorx, Inc.

Jun 26, 2024 @ 12:30 PM University of Nebraska Medical Center Launches Pat... Source: RenovoRx, Inc.

Jun 10, 2024 @ 12:30 PM RenovoRx Appoints Ryan Witt as Senior Vice Preside... Source: RenovoRx, Inc.

Jan 2, 2024 @ 6:35 PM Why Longboard Pharmaceuticals Shares Are Trading H... Source: Avi Kapoor

Dec 28, 2023 @ 6:07 PM Why DouYu International Shares Are Trading Higher ... Source: Avi Kapoor

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.31	$-.06	$-.09
Diluted EPS	$-.31	$-.06	$-.09
Revenue	$2.22M	$.91M	$.56M
Gross Profit	$1.67M	$.77M	$.48M
Net Income / Loss	$-12.29M	$-2.91M	$-3.52M
Operating Income / Loss	$-13.54M	$-3.35M	$-3.47M
Cost of Revenue	$.31M	$.14M	$.08M
Net Cash Flow	$-2.84M	$2.46M	$M
PE Ratio